Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer's Disease

被引：7
|
作者：
Lou, Guofeng [1 ,2 ]
Zhang, Qihao [1 ,2 ]
Xiao, Fei [3 ]
Xiang, Qi [1 ,2 ]
Su, Zhijian [1 ,2 ]
Huang, Yadong [1 ,2 ]
机构：
[1] Jinan Univ, Inst Biomed, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[2] Jinan Univ, Dept Cell Biol, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China
[3] Jinan Univ, Dept Pharmacol, Guangzhou 510632, Guangdong, Peoples R China
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2016年 / 51卷 / 04期
关键词：
A beta PP/PS1; Alzheimer's disease; haFGF; intranasal administration; TAT; CENTRAL-NERVOUS-SYSTEM; FOCAL CEREBRAL-ISCHEMIA; MEDIATED DELIVERY; MICE; FGF; NEURODEGENERATION; MECHANISMS; PROTEINS; GDNF;
D O I：
10.3233/JAD-151121
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Neurotoxic amyloid-beta (A beta) peptide causing cognitive function disabilities is one of the most characteristic pathological features in Alzheimer's disease (AD). A novel fusion protein, TAT-haFGF, was administrated to A beta PP/PS1 transgenic mice by intravenous (IV) injection and intranasal (IN) delivery, respectively, for 5 weeks to compare the pharmacodynamics between the two routes of administration. Our results showed that IN administration of TAT-haFGF improved cognition and reduced A beta plaques more significantly in A beta PP/PS1 mice, when compared with IV injection. Our new findings suggest that TAT-haFGF might be a promising new therapy to attenuate AD pathological process.
引用
收藏
页码：985 / 990
页数：6
相关论文
共 50 条
  • [31] Early Neuronal Loss and Axonal/Presynaptic Damage is Associated with Accelerated Amyloid-β Accumulation in AβPP/PS1 Alzheimer's Disease Mice Subiculum
    Trujillo-Estrada, Laura
    Davila, Jose Carlos
    Sanchez-Mejias, Elisabeth
    Sanchez-Varoa, Raquel
    Gomez-Arboledas, Angela
    Vizuete, Marisa
    Vitorica, Javier
    Gutierreza, Antonia
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (02) : 521 - 541
  • [32] Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease
    Huang, Min
    Jiang, Xin
    Liang, Yubin
    Liu, Qiong
    Chen, Siyan
    Guo, Yi
    EXPERIMENTAL GERONTOLOGY, 2017, 91 : 25 - 33
  • [33] Effect of Herbal Medicinal Compounds on Alzheimer's Disease Pathology in APP/PS1 Transgenic Mouse Model Natural
    Li, Xuexia
    He, Zhijun
    Wang, Chao
    Liu, Yanjun
    Shan, Zhifu
    Zhang, Lei
    Shi, Qingqing
    Yue, Caiping
    Lin, Yitong
    Liu, Yun
    Ni, Jiazuan
    Du, Xiubo
    NATURAL PRODUCT COMMUNICATIONS, 2020, 15 (08)
  • [34] Rhynchophylline Administration Ameliorates Amyloid-β Pathology and Inflammation in an Alzheimer's Disease Transgenic Mouse Model
    Fu, Wing-Yu
    Hung, Kwok-Wang
    Lau, Shun-Fat
    Butt, Busma
    Yuen, Vincent Wai-Hin
    Fu, Guangmiao
    Chan, Ivy C.
    Ip, Fanny C. F.
    Fu, Amy K. Y.
    Ip, Nancy Y.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (22): : 4249 - 4256
  • [35] Amyloid-β specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice
    Yeapuri, Pravin
    Machhi, Jatin
    Lu, Yaman
    Abdelmoaty, Mai Mohamed
    Kadry, Rana
    Patel, Milankumar
    Bhattarai, Shaurav
    Lu, Eugene
    Namminga, Krista L.
    Olson, Katherine E.
    Foster, Emma G.
    Mosley, R. Lee
    Gendelman, Howard E.
    MOLECULAR NEURODEGENERATION, 2023, 18 (01)
  • [36] Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
    Pravin Yeapuri
    Jatin Machhi
    Yaman Lu
    Mai Mohamed Abdelmoaty
    Rana Kadry
    Milankumar Patel
    Shaurav Bhattarai
    Eugene Lu
    Krista L. Namminga
    Katherine E. Olson
    Emma G. Foster
    R. Lee Mosley
    Howard E. Gendelman
    Molecular Neurodegeneration, 18
  • [37] Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology
    Reale, Marcella
    D'Angelo, Chiara
    Costantini, Erica
    Di Nicola, Marta
    Yarla, Nagnedra Sastry
    Kamal, Mohammad Amjad
    Salvador, Nieves
    Perry, George
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (01) : 467 - 476
  • [38] Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease
    Francis, Yitshak I.
    Fa, Mauro
    Ashraf, Haider
    Zhang, Hong
    Staniszewski, Agnieszka
    Latchman, David S.
    Arancio, Ottavio
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (01) : 131 - 139
  • [39] Vascular and metabolic dysfunctions in APP/PS1 mouse model of Alzheimer's disease
    Iordanova, B.
    Fukuda, M.
    Klunk, W.
    Vazquez, A. L.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 44 - 45
  • [40] Mechanical alterations of the hippocampus in the APP/PS1 Alzheimer's disease mouse model
    Antonovaite, Nelda
    Hulshof, Lianne A.
    Huffels, Christiaan F. M.
    Hol, Elly M.
    Wadman, Wytse J.
    Iannuzzi, Davide
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2021, 122
12345